Hypera (OTCMKTS:HYPMY) Stock Crosses Below 50-Day Moving Average of $8.19
Hypera (OTCMKTS:HYPMY) Stock Crosses Below 50-Day Moving Average of $8.19
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.19 and traded as low as $8.03. Hypera shares last traded at $8.22, with a volume of 2,874 shares changing hands.
Hypera Trading Up 2.9 %
The firm has a market capitalization of $5.21 billion, a PE ratio of 19.69 and a beta of 0.80. The business has a 50 day moving average price of $8.19 and a 200-day moving average price of $7.84.
Hypera Company Profile
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.19 and traded as low as $8.03. Hypera shares last traded at $8.22, with a volume of 2,874 shares changing hands.
Hypera S.A.(场外交易代码：HYPMY-GET Rating)股价在周五的交易中跌破50日移动均线。该股的50日移动均线为8.19美元，交易价格低至8.03美元。Hypera股票最新报8.22美元，成交量为2,874股。
Hypera Trading Up 2.9 %
Hypera股价上涨2.9%
The firm has a market capitalization of $5.21 billion, a PE ratio of 19.69 and a beta of 0.80. The business has a 50 day moving average price of $8.19 and a 200-day moving average price of $7.84.
该公司市值为52.1亿美元，市盈率为19.69倍，贝塔系数为0.80。该业务的50日移动均线价格为8.19美元，200日移动均线价格为7.84美元。
Hypera Company Profile
Hypera公司简介
(Get Rating)
(获取评级)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作为一家制药公司运营。它提供的处方药有Adacne、Addera、Apri、AmpliumG、请、赛莱他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、双丙胺、双丙沙星、双丙松、双丙松、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混悬剂、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- 免费获取StockNews.com关于Hypera的研究报告(HYPMY)
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何？
- 让Paychex股票为您努力工作
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Hypera和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧